March Final Issue.pmd - CHANGE 'Gateway to All Competitive Exams'
March Final Issue.pmd - CHANGE 'Gateway to All Competitive Exams'
March Final Issue.pmd - CHANGE 'Gateway to All Competitive Exams'
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
MARCH 2012 Get Previous <strong>Issue</strong>s Free of Cost on Our Website: www.changetabloid.com<br />
HEALTH COVERAGE<br />
2012: Year of Intensification of<br />
Routine Immunization<br />
India has declared year 2012 as the year of intensification<br />
of routine immunization. The present full immunization<br />
coverage of children is 61%. The key objective of this<br />
campaign is <strong>to</strong> improve full immunization coverage and<br />
reach all children, particularly in remote, inaccessible<br />
and backward areas as well as in urban slums. The<br />
strategies that are being deployed include:<br />
• Updating of Micro plans <strong>to</strong> cover all villages<br />
and hamlets in the country;<br />
• Special immunization drives in pockets of low<br />
immunization coverage;<br />
• Intensification of immunization activity by<br />
observing immunization weeks in low<br />
performing states;<br />
• IEC related activities for demand generation<br />
<strong>to</strong>wards immunization;<br />
• Deployment of adequate number of Health<br />
workers;<br />
• Prioritization of areas with exclusive strategy<br />
for 200 districts poor performing districts in the<br />
country;<br />
• And Special focus on migrant and mobile<br />
populations.<br />
Government of India has also expanded the Universal<br />
Immunization Progranme (UIP) by introducing 2nd dose<br />
of Measles, Hepatitis B and Pentavalent vaccination:<br />
India has introduced second dose of measles vaccine in<br />
UIP. The target is <strong>to</strong> vaccinate more than 12 crore children<br />
through Supplementary Immunization Activity (SIA) in<br />
14 states of which 3.4 crore children have already been<br />
vaccinated. This will prevent an estimated 1 lakh measles<br />
related death. Hepatitis B has been expanded and<br />
universalized across the entire country. Pentavalent, a<br />
combination vaccine against five diseases (Diphtheria,<br />
Pertussis, Tetanus, Hepatitis B and Haemophilus<br />
influenza B) has been introduced on pilot basis in 2<br />
States – Tamil Nadu and Kerala – in mid December 2011.<br />
The initial response of the community has been very<br />
encouraging and more than one lakh children have been<br />
successfully vaccinated within the 1st month.<br />
In order <strong>to</strong> track every child for assured delivery of<br />
immunization services, a web enabled name based<br />
tracking system has been put in place with a database<br />
of more than 10 million children. Parents are being sent<br />
SMS alerts before the due date of vaccination and health<br />
workers are also now receiving the list of children due<br />
for vaccination through SMS. This is expected <strong>to</strong><br />
improve immunization coverage substantially within the<br />
next one year and facilitate real time reporting on<br />
immunization coverage.<br />
Molecular Pathology Boon for<br />
Prenatal Diagnosis: Expert<br />
Around half a million newborns in India suffer from<br />
congenital genetic disorders every year – the highest in<br />
the world – but advances like molecular pathology have<br />
helped detecting these disorders at early stages, an<br />
expert said.<br />
“The number of children born with genetic disorders in<br />
India is highest in the world,” I.C. Verma, direc<strong>to</strong>r, Sir<br />
Ganga Ram hospital, said at International Symposium<br />
on Molecular Pathology.<br />
However, because of advancements like molecular<br />
pathology, the cases of genetic disorders are being<br />
detected at an early stage. “There has been an increase<br />
in prenatal diagnosis in such cases and its success is<br />
above 30 percent,” Verma said.<br />
Molecular pathology is a discipline within pathology<br />
which focuses on the study and diagnosis of disease<br />
through the examination of molecules within organs,<br />
tissues or bodily fluids.<br />
India Declared itself Free from<br />
Bird Flu, H5N1<br />
India became free from bird flu, H5N1. The government<br />
made a declaration <strong>to</strong> this effect on 4 January 2012. The<br />
states were advised <strong>to</strong> have strict surveillance, especially<br />
in the vulnerable areas bordering the infected countries<br />
and in areas visited by migra<strong>to</strong>ry birds.<br />
WHAT IS H5N1<br />
Influenza A virus subtype H5N1 is also known as bird<br />
flu , A(H5N1) or simply H5N1, is a subtype of the<br />
influenza A virus .It can cause illness in humans and<br />
many other animal species.<br />
HIV Drug now Available as Oral<br />
Powder for Children<br />
The HIV drug Viread will now be available in powder<br />
form for HIV positive children after its approval by the<br />
US Food and Drug Administration (FDA), a biopharmaceutical<br />
company said. The move is expected <strong>to</strong><br />
benefit millions of HIV positive children.<br />
The FDA also approved a New Drug Application (NDA)<br />
for an oral powder formulation of Viread for children<br />
ages 2-5. The active ingredient in Viread, tenofovir<br />
disoproxil fumarate, is currently the most-prescribed<br />
molecule for adults receiving HIV therapy in the United<br />
States.<br />
In pediatric patients, the use of either the lower-strength<br />
tablets or the oral powder formulation of Viread is based<br />
on the patient’s age and weight. The safety and efficacy<br />
of Viread has not been established in children less than<br />
two years of age. For adults unable <strong>to</strong> swallow Viread<br />
tablets, the oral powder formulation equal <strong>to</strong> 300 mg<br />
may be used.<br />
According <strong>to</strong> the World Health Organization (WHO),<br />
there are approximately 2.5 million children under the<br />
age of 15 living with HIV worldwide, and more than 90<br />
percent live in sub-Saharan Africa.<br />
WHO Recognizes Progress of Gulf<br />
States for Adopting Regional<br />
Strategy <strong>to</strong> Address Non<br />
communicable Diseases<br />
The Gulf Cooperation Council (GCC), whose Ministers<br />
of Health met in Muscat, Oman is the first regional entity<br />
<strong>to</strong> respond, at a heads of state level, <strong>to</strong> the UN General<br />
Assembly Political Declaration on the Prevention and<br />
Control of Noncommunicable Diseases (NCDs) by<br />
developing a regional strategy <strong>to</strong> address diseases, such<br />
as diabetes, cardiovascular disease, cancer and chronic<br />
respira<strong>to</strong>ry disease.<br />
Putting Commitments in<strong>to</strong> Action<br />
The strategy outlines a plan <strong>to</strong> put in<strong>to</strong> action the<br />
commitments agreed upon in September in the UN<br />
General Assembly’s Political Declaration on NCDs.<br />
NCDs cause more than 60% of all deaths in GCC<br />
countries, and are caused by shared risk fac<strong>to</strong>rs like<br />
<strong>to</strong>bacco use, unhealthy diet and physical inactivity.<br />
“The regional strategy details what the six countries<br />
(Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, United<br />
Arab Emirates) will be doing <strong>to</strong> tackle NCDs during the<br />
next years in terms of reducing people’s exposure <strong>to</strong><br />
causative risk fac<strong>to</strong>rs and improving services <strong>to</strong> prevent<br />
and treat these leading health problems,” said Dr Ahmed<br />
Al Saidi, Omani Minister of Health who chaired the<br />
meeting. “It also highlights what the six countries will<br />
do <strong>to</strong> set targets and measure results, advance<br />
multisec<strong>to</strong>ral action, and strengthen national capacity.”<br />
Reducing Premature Deaths<br />
The Oman meeting followed a two-day summit in<br />
December where heads of state of the Cooperation<br />
Council for the Arab States of the Gulf endorsed a<br />
regional approach <strong>to</strong> reduce premature deaths from<br />
noncommunicable diseases.<br />
Welcoming the announcement, WHO Regional Direc<strong>to</strong>r-<br />
Elect of WHO’s Eastern Mediterranean Region Dr Ala<br />
Alwan said, “We have the knowledge of what works <strong>to</strong><br />
prevent and treat NCDs, a global public health and<br />
development problem of increasing significance <strong>to</strong> many<br />
countries. We are pleased <strong>to</strong> see the Gulf Cooperation<br />
Council countries taking concrete action <strong>to</strong> implement<br />
affordable best practices (called ‘best buys’) <strong>to</strong> curb<br />
NCDs and we hope other regions will take similar action.”<br />
“Up <strong>to</strong> 50% of people dying from these diseases in some<br />
of the Gulf countries die prematurely, before the age of<br />
60 years. This initiative by the GCC should be a major<br />
landmark in s<strong>to</strong>pping these premature deaths,” said<br />
Alwan.<br />
DRDO’s Rs.7 cr Tulsi Project finds<br />
Anti Radiation Properties of Tulsi<br />
Extracts in Animal Trials<br />
There are more revelations coming <strong>to</strong> light about the<br />
home grown tulsi plant’s medicinal values. In a recent<br />
research conducted by scientists at DRDO’s (Defence<br />
Research Development Organization) Institute of<br />
Nuclear Medicines and <strong>All</strong>ied Sciences and Department<br />
of Radiobiology, Kasturba Medical College, Manipal,<br />
the scientists have successfully tested tulsi extracts on<br />
mice for its anti-radiation and anti-cancer properties. The<br />
DRDO is spending Rs.7 crore on the tulsi project.<br />
Earlier, the research students at the department of<br />
biotechnology of Vignan College in Gun<strong>to</strong>or, in Andhra<br />
Pradesh, had also revealed that Tulsi extracts had useful<br />
medicinal ingredients which can treat diabetics and<br />
cancerous ailments in humans.<br />
Now as the scientists have discovered one more<br />
medicinal value in tulsi extract which can be used as an<br />
anti-radiation agent, it is evidently proved that the<br />
ancient Indian tradition of growing tulsi (Ocimum<br />
Santum) in the backyard is not without scientific backing.<br />
With this new revelation, it can be said that tulsi plant is<br />
embedded with multiple medicinal values, as it can be<br />
used not only <strong>to</strong> treat diabetics, but also can be used for<br />
treating cancer and now as an anti-radiant substance.<br />
Research shows that the tulsi or Indian basil contains a<br />
chemical called glutathione which mitigates the ill-effects<br />
of radiation and can protect cells in patients undergoing<br />
radiation therapy for cancer. In fact when anybody is<br />
subjected <strong>to</strong> radiation, it affects the bone marrow first<br />
and thus the immunity level comes down. This will make<br />
the human body vulnerable for contracting diseases<br />
easily.<br />
Initially the scientists used tulsi extract on mice and<br />
they successfully found that the bone marrow of radiation<br />
exposed rodents was not affected and their immunity<br />
levels were intact. With this new success, the DRDO is<br />
now preparing a herbal concoction from tulsi that will<br />
serve <strong>to</strong> prevent and cure the ill-effects of radiation.<br />
Dr W Selvamurthy, chief controller (research and<br />
development) revealed that now DRDO is planning <strong>to</strong><br />
take up human trials. “We need <strong>to</strong> conduct a few more<br />
tests and take up phase II trials before it is released for<br />
general use,” said Dr Selvamurthy.<br />
In fact, the research on the anti-radiation effect of tulsi<br />
in animals has been going on in India since the past 40<br />
years and it is only in the recent years that scientist<br />
have been coming out with concrete evidence of tulsi’s<br />
mythic medicinal values.<br />
Health Scheme Approved for<br />
Nepal-domiciled Gorkhas<br />
The union cabinet approved the extension of the Ex-<br />
Servicemen Contribu<strong>to</strong>ry Health Scheme (ECHS) <strong>to</strong><br />
Nepal-domiciled Gorkha (NDG) pensioners in a decision<br />
expected <strong>to</strong> benefit around one lakh Indian exservicemen.<br />
There are about one lakh Indian exservicemen<br />
and 2.17 lakh dependents domiciled in Nepal<br />
who will benefit from the ECHS. They are so far entitled<br />
<strong>to</strong> medical treatment under ECHS at polyclinics and<br />
ECHS-empanelled civil hospitals in India.<br />
Considering the practical difficulties being faced by<br />
Nepal-domiciled Gorkha ex-servicemen in availing<br />
treatment, the government has decided <strong>to</strong> provide<br />
medical facilities <strong>to</strong> them in Nepal itself. The ECHS<br />
provides comprehensive and quality healthcare benefits<br />
<strong>to</strong> pensioner ex-servicemen residing in India. Extending<br />
it <strong>to</strong> Nepal for Nepal-domiciled Gorkha ex-servicemen<br />
would meet a long-standing need for providing<br />
healthcare <strong>to</strong> them.<br />
<strong>All</strong> other policies and procedures of ECHS which are<br />
applicable in India will also apply <strong>to</strong> pensioner NDGs<br />
ex-servicemen in Nepal.<br />
Infotech can Improve Healthcare in India: Nasscom<br />
Information technology (IT) can make healthcare accessible and affordable <strong>to</strong> more people in the country, industry<br />
lobby the National Association of Software and Services Companies (Nasscom) said. “IT can provide access <strong>to</strong><br />
healthcare facilities. Also, it can have a positive impact on affordability and effectiveness of healthcare in India,”<br />
Som Mittal, president of the IT-BPO sec<strong>to</strong>r apex body, said at the ‘Health 2.02 conference.<br />
Experts from the healthcare sec<strong>to</strong>r have come <strong>to</strong>gether for the first conference that emphasizes on innovation and<br />
IT in health services. In the country’s 12th Five Year Plan (2012-2017), the Planning Commission is likely <strong>to</strong> increase<br />
the spending on healthcare <strong>to</strong> increase its affordability and accessibility.<br />
<strong>CHANGE</strong> THE ONLY CONSTANT THING : We Bring You More Informative and Detailed Coverage Every Month 20